Skip to content
by Legal Desire
4 October 2023

Latham & Watkins Advises on the Transfer of LimaCorporate From EQT to Enovis

M&A Healthcare & Life Sciences Expected to close

Advising firms

Deal team

13 lawyers named
LawyerFirmSeniorityPracticeOffice
Cataldo Piccarreta Lead Latham & Watkins LLP Partner corporate Not stated
Maria Giulia De Cesari Latham & Watkins LLP Associate corporate Not stated
Federica Di Terlizzi Latham & Watkins LLP Associate corporate Not stated
Sebastian Max Hauser Latham & Watkins LLP Partner antitrust Not stated
Giuseppe Liotine Latham & Watkins LLP Associate antitrust Not stated
Joseph Kimberling Latham & Watkins LLP Partner finance Not stated
Patrick Kwak Latham & Watkins LLP Partner finance Not stated
Jason Morelli Latham & Watkins LLP Partner finance Not stated
Yoseph Choi Latham & Watkins LLP Counsel finance Not stated
Taniel Akay Latham & Watkins LLP Associate finance Not stated
Medha Vikram Latham & Watkins LLP Associate finance Not stated
Cesare Milani Latham & Watkins LLP Partner regulatory Not stated
Edoardo Cassinelli Latham & Watkins LLP Associate regulatory Not stated

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Not stated
Counterparties
EQT Private Equity (Sell-side)
Enovis™ Corporation (Buy-side)
LimaCorporate S.p.A. (Target)